--- title: How much of PMDD treatment improvement comes from placebo effect? description: The placebo effect accounts for 20.9% to 38.4% of treatment improvement, depending on which symptom is measured. Measuring total symptoms rather than individu url: https://niyora.com/research/papers/quantitative-analysis-of-placebo-response-models-to-optimize-clinical-trials-in-2026/ --- - [Niyora](https://niyora.com/) - [Research](https://niyora.com/research/) - [Library](https://niyora.com/research/library/) - How much of PMDD treatment improvement comes from placebo effect? Systematic review, 2026 # How much of PMDD treatment improvement comes from placebo effect? The placebo effect accounts for 20.9% to 38.4% of treatment improvement, depending on which symptom is measured. Measuring total symptoms rather than individual symptoms like depression gives more reliable results for testing new treatments. Strong study design 5406 patients from 47 randomized controlled trials about premenstrual disorders ## What they did A model-based meta-analysis of 47 randomized controlled trials about premenstrual disorders involving 5406 patients. Researchers analyzed how well five common ways of measuring symptoms predict whether a treatment works. ## What they found Five common measurements were identified: total symptom score, depression symptoms, anxiety symptoms, irritability symptoms, and physical symptoms. The maximum placebo response ranged from 20.9% to 38.4%, with improvements reaching their peak within 2 to 3 months. Total symptom score had the smallest placebo response (most reliable measurement) and the quickest response to treatment. The supplement S-equol showed no real benefit beyond placebo. ## What it means for you About one-fifth to one-third of treatment benefit comes from placebo effect. This helps scientists understand whether treatments actually work. Measuring total symptoms gives more reliable results than individual symptoms. This information helps researchers design better studies. 5406 Patients analyzed 47 Randomized controlled trials 20.9% to 38.4% Placebo response range ## About the study Original title Quantitative Analysis of Placebo Response Models to Optimize Clinical Trials in Premenstrual Disorders: A Model-Based Meta-analysis Authors Yang X, Lv Y, Liu Y et al. Journal Biopsychosocial science and medicine Year 2026 Study design Systematic review What was tested Various medications and supplements for PMDD including S-equol Read the paper [doi.org/10.1097/psy.0000000000001491](https://doi.org/10.1097/psy.0000000000001491) ## Topics [Premenstrual syndrome (PMS)](https://niyora.com/research/topics/condition-pms/)[Premenstrual dysphoric disorder (PMDD)](https://niyora.com/research/topics/condition-pmdd/)[Low mood and depression](https://niyora.com/research/topics/symptom-depression-mood/) Research tells you what helps on average. Niyora helps on the day it hits. Calm down, see it another way, and decide what to say, with a PMS and PMDD app built by a doctor. ## Related studies Cohort study, 2026 What genetic factors are linked to premenstrual symptoms? Systematic review, 2026 How often do mood disorders and PMS or PMDD occur together? Systematic review, 2026 Does vitamin D supplementation help PMS symptoms? Study, 2026 How do women with PMDD process emotions differently in their brains? Systematic review, 2026 Why do some women experience mood changes linked to their menstrual cycle? Case-control study, 2026 Do women with PMS handle emotions differently at different times of the cycle? Ask AI about this page Copy prompt ChatGPT ↗ Claude ↗ Perplexity ↗ Google AI Mode ↗ Grok ↗